Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection
PLOS One · 2026
DOI: 10.1371/journal.pone.0339580 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Zahra Khosravi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Industrial Engineering, Iran University of Science and Technology, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Machine Learning, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Künstliche Intelligenz in der Pflege, Diabetes mellitus
Abstract (Originalsprache)
Metabolic-Associated Fatty Liver Disease (MAFLD) is common among Type 2 Diabetes (T2DM) patients. The coexistence of these conditions increases the risk of MAFLD progression and diabetes complications. Detecting MAFLD early is challenging due to its asymptomatic initial stages. In this study, we aimed to develop a machine learning model to predict MAFLD in T2DM patients. We conducted a cross-sectional study on 3,654 Iranian T2DM patients using their demographic and lab data. This study involved thorough data preprocessing, including evaluating various imputation methods on simulated missingness in a complete subset of the dataset. Additionally, four feature selection methods were applied to eight machine learning models to identify the most effective predictive model. The XGBoost classifier without feature selection achieved the best performance, with an accuracy of 80.6% and an area under the receiver operating characteristic curve (AUC) of 88.9%.Notably, certain features, such as alanine aminotransferase (ALT), platelet count (PLT) and Vitamin D(VitD) influenced the predictive performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Industrial Engineering, Iran University of Science and Technology, Tehran, Iran.
- Endocrinology and Metabolism Research Center (EMRC), Imam Khomeini Hospital Complex, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Farnaz Barzinpour
Zitieren
APA
Khosravi, Z., Barzinpour, F., Rabizadeh, S., Nakhjavani, M., & Esteghamati, A. (2026). Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection. PLOS One. https://doi.org/10.1371/journal.pone.0339580
Vancouver
Khosravi Z, Barzinpour F, Rabizadeh S, Nakhjavani M, Esteghamati A. Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection. PLOS One. 2026. doi:10.1371/journal.pone.0339580
BibTeX
@article{Khosravi2026,
author = {Khosravi, Zahra and Barzinpour, Farnaz and Rabizadeh, Soghra and Nakhjavani, Manouchehr and Esteghamati, Alireza},
title = {Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0339580}
}
EUVIMED